(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 22.48% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.43%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.15%.
Evolent Health's revenue in 2026 is $1,888,826,000.On average, 17 Wall Street analysts forecast EVH's revenue for 2026 to be $283,114,845,639, with the lowest EVH revenue forecast at $268,154,863,728, and the highest EVH revenue forecast at $308,423,085,714. On average, 17 Wall Street analysts forecast EVH's revenue for 2027 to be $337,218,238,866, with the lowest EVH revenue forecast at $316,746,684,672, and the highest EVH revenue forecast at $370,737,596,832.
In 2028, EVH is forecast to generate $389,859,378,222 in revenue, with the lowest revenue forecast at $356,115,058,122 and the highest revenue forecast at $421,691,520,183.